Human Papillomavirus 31 Tyrosine 102 Regulates Interaction with E2 Binding Partners and Episomal Maintenance

dc.contributor.authorGilson, Timra
dc.contributor.authorCulleton, Sara
dc.contributor.authorXie, Fang
dc.contributor.authorDeSmet, Marsha
dc.contributor.authorAndrophy, Elliot J.
dc.contributor.departmentDermatology, School of Medicineen_US
dc.date.accessioned2022-04-27T15:35:02Z
dc.date.available2022-04-27T15:35:02Z
dc.date.issued2020-07-30
dc.description.abstractSeveral serine and threonine residues of the papillomavirus early E2 protein have been found to be phosphorylated. In contrast, only one E2 tyrosine phosphorylation site in BPV-1 (tyrosine 102) and one in HPV-16/31 (tyrosine 138) site have been characterized. Between BPV-1 and HPV-31 E2, 8 of the 11 tyrosines are conserved in the N-terminal domain, suggesting that phosphorylation of tyrosines has an essential role in E2 biology. In this study, we examine the effect of Y102 phosphorylation on HPV-31 E2 biology. Y102 proteins mutated either to the potential phospho-mimetic glutamic acid (Y102E) or to the nonphosphorylated homologue phenylalanine (Y102F) remain nuclear; however, Y102E is more associated with the nuclear matrix fraction. This is consistent with the inability of Y102E to bind TopBP1. Both BPV-1 and HPV-31 Y102E are similar in that neither binds the C terminus of Brd4, but in all other aspects the mutant behaves differently between the two families of papillomaviruses. BPV-1 Y102E was unable to bind E1 and did not replicate in a transient in vitro assay, while HPV-31 Y102E binds E1 and was able to replicate, albeit at lower levels than wild type. To examine the effect of E2 mutations under more native-like infection conditions, a neomycin-selectable marker was inserted into L1/L2 of the HPV-31 genome, creating HPV-31neo. This genome was maintained in every cell line tested for at least 50 days posttransfection/infection. Y102E in both transfection and infection conditions was unable to maintain high episome copy numbers in epithelial cell lines.IMPORTANCE Posttranslational modifications by phosphorylation can change protein activities, binding partners, or localization. Tyrosine 102 is conserved between delta papillomavirus BPV-1 and alpha papillomavirus HPV-31 E2. We characterized mutations of HPV-31 E2 for interactions with relevant cellular binding partners and replication in the context of the viral genome.en_US
dc.eprint.versionFinal published versionen_US
dc.identifier.citationGilson T, Culleton S, Xie F, DeSmet M, Androphy EJ. Human Papillomavirus 31 Tyrosine 102 Regulates Interaction with E2 Binding Partners and Episomal Maintenance. J Virol. 2020;94(16):e00590-20. Published 2020 Jul 30. doi:10.1128/JVI.00590-20en_US
dc.identifier.urihttps://hdl.handle.net/1805/28793
dc.language.isoen_USen_US
dc.publisherAmerican Society for Microbiologyen_US
dc.relation.isversionof10.1128/JVI.00590-20en_US
dc.relation.journalJournal of Virologyen_US
dc.rightsPublisher Policyen_US
dc.sourcePMCen_US
dc.subjectHPVen_US
dc.subjectTyrosine phosphorylationen_US
dc.subjectViral replicationen_US
dc.titleHuman Papillomavirus 31 Tyrosine 102 Regulates Interaction with E2 Binding Partners and Episomal Maintenanceen_US
dc.typeArticleen_US
ul.alternative.fulltexthttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394896/en_US
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
JVI.00590-20.pdf
Size:
1.29 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: